WORLD TRADE  
ORGANIZATION  G/TBT/N/EEC/291 
14 August 2009  
 (09-3888) 
Committee on Technical Barriers to Trade Original:   English 
 
 
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6 
 
1. Member to Agreement notifying:  EUROPEAN COMMUNITIES   
If applicable, name of local government involved (Article 3.2 and 7.2):     
2. Agency responsible:  European Commission 
Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be  indicated if different from above :   
European Commission EC-TBT Enquiry Point 
Fax:  +(32) 2 299 80 43 E-mail:  ec-tbt@ec.europa.eu Website: http://ec.europa.eu/enterprise/tbt/
  
3. Notified under Article 2.9.2 [ X ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:   
4. Products covered (HS or CCCN where applicab le, otherwise national tariff heading. 
ICS numbers may be provided in addition, where applicable):  Acrolein, Warfarin, 
Warfarin Sodium, Diazinon, Magnesium Phos phide, Aluminium Phosphide, Brodifacoum 
5. Title, number of pages and langua ge(s) of the notified document:   
- Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include acrolein as an active substance in Annex I thereto (6 pages, in 
English) 
- Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include warfarin as an active substance in Annex I thereto (7 pages, in  
English). - Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include warfarin sodium as an active substance in Annex I thereto (7 
pages, in English). - Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include magnesium phosphide as an active substance in Annex I thereto (7 
pages, in English). - Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include aluminium phosphide as an active substance in Annex I thereto (7 
pages, in English). - Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include brodifac oum as an active substance in Annex I thereto (6 pages, in 
English). G/TBT/N/EEC/291 
Page 2  
 
  - Draft Commission Decision concerning the non-inclusion of diazinon in Annex I, IA or IB 
to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (5 pages, in English). 
- Draft Commission Decision concerning the non- inclusion of certain substances in Annex 
I, IA or IB to Directive 98/8/EC of the Eur opean Parliament and of the Council concerning 
the placing of biocidal products on the market (13 pages, in English). 
6. Description of content:  The six draft Commission Directives include acrolein, warfarin,  
warfarin sodium, aluminium phosphide, magn esium phosphide and brodifacoum in the 
European Community positive list of active s ubstances, which may be used in biocida l 
products. The two draft Co mmission Decisions concern a list of active s ubstances for which the 
industry had initially  notified their intention to submit information for thei r risk and 
efficacy assessment - and on this basis they we re allowed to remain on the biocides market. 
However, when the deadline for subm ission of this information arrived, no dossiers were 
submitted. Consequently, these substances will not be examined under the 10-year review 
programme established by Article 16(2) of the Biocides Directive 98/8/EC, and a decision 
should now be taken to remove them from the biocides market, after a 12-month phase-out 
period. A longer phase-out period has been set for diazinon used in flea collars to allow for 
their authorisation as veterinary medicinal pr oducts in accordance with the applicable EU  
legislation. 
7. Objective and rationale, including the natu re of urgent problems where applicable:  
Protection of public health and of the envi ronment. Harmonisation of the EU market on 
biocidal products. 
8. Relevant documents:   Directive 98/8/EC of the European Parliament and the Council on 
the placing of biocidal products on the market  (OJ L 123, 24.4.1998, page 1). Available in 
all EU languages. http://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:1998:123:SOM:EN:HTML  
9. Proposed date of adoption:   
Proposed date of entry into force:    1 March 2010   20  days from publication in the Official 
Journal of the EU  
10. Final date for comments:  60 days from date of notification.  G/TBT/N/EEC/291 
 Page 3 
 
 
  11. Text available from: National enquiry point [  ], or address, telephone and fax 
numbers, e-mail and web-site addresses, if available of the other body:    
European Commission, 
EC-TBT Enquiry Point, Fax:  + (32) 2 299 80 43, 
E-mail:  ec-tbt@ec.europa.eu 
The text is available on the EC-TBT Website :  http://ec.europa.eu/enterprise/tbt/ 
  
And can also be downloaded below:  
Acrolein 
Warfarin 
Warfarin Sodium  
Magensium Phosphide  
Aluminium Phosphide  
Brodifacoum  
Diazinon 
Certain substances